S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|NPSP INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. in Connection with the Fairness of the Sale of the Company to Shire plc (2015/1/16)|
|NPSP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Regarding the Fairness of the Sale of the Company to Shire plc-- NPSP (2015/1/12)|
|NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc (2015/1/14)|
|EQUITY ALERT: The Rosen Law Firm Announces Investigation of NPS Pharmaceuticals Concerning its Proposed Sale to Shire – NPSP|
|SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information|
|NPS PHARMA ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of NPS Pharmaceuticals, Inc. to Shire plc|
|NPS PHARMACEUTICALS INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Shire PLC (2015/1/12)|
|NPS PHARMACEUTICALS, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Shire Plc - NPSP|
|PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech|
|Robbins Arroyo LLP: Acquisition of NPS Pharmaceuticals, Inc. (NPSP) by Shire PLC (SHP) May Not Be in Shareholders' Best Interests|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
Click above to view more mutual fund data and stats for npsp - NPS Pharmaceuticals Inc.